Lack of effect of intravenous immunoglobulins on tics: A double-blind placebo-controlled study

Journal of Clinical Psychiatry

Volumn 65, Issue 4, 2004, Pages 537-542

  Hoekstra, Pieter J ^a   Minderaa, Ruud B ^a   Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGICAL ADJUVANT; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HOSPITALIZATION; HUMAN; IMMUNOLOGY; MALE; OBSESSIVE COMPULSIVE DISORDER; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; TIC; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TIC DISORDERS; TICS; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 2442541126     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0413     Document Type: Article

References (27)

1. Kushner HI. A Cursing Brain? The Histories of Tourette Syndrome. Cambridge, Mass: Harvard University Press; 1999
2. Jankovic J. Tourette's syndrome. N Engl J Med 2001;345:1184-1192 (Pubitemid 34940764)
3. Kurlan R, Como PG, Miller B, et al. The behavioral spectrum of tic disorders: a community-based study. Neurology 2002;59:414-420 (Pubitemid 34857935)
4. Coffey BJ, Biederman J, Geller DA, et al. The course of Tourette's disorder: a literature review. Harv Rev Psychiatry 2000;8:192-198 (Pubitemid 30809109)
5. Hoekstra PJ, Kallenberg CG, Korf J, et al. Is Tourette's syndrome an autoimmune disease? Mol Psychiatry 2002;7:437-445
6. Muller N, Kroll B, Schwarz MJ, et al. Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res 2001;101:187-193 (Pubitemid 32245801)
7. Wendlandt JT, Grus FH, Hansen BH, et al. Striatal antibodies in children with Tourette's syndrome: multivariate discriminant analysis of IgG repertoires. J Neuroimmunol 2001;119:106-113 (Pubitemid 32781735)
8. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271 (Pubitemid 28074291)
9. Kondo K, Kabasawa T. Improvement in Gilles de la Tourette syndrome after corticosteroid therapy. Ann Neurol 1978;4:387 (Pubitemid 9009905)
10. Matarazzo EB. Tourette's syndrome treated with ACTH and prednisone: report of two cases. J Child Adolesc Psychopharmacol 1992;2:215-226
11. Geschwind N, Kondo K. Corticosteroid therapy and Tourette syndrome [letter]. Ann Neurol 1979;5:495 (Pubitemid 9150147)
12. Tucker DM, Leckman JF, Scahill L, et al. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry 1996;35:1684-1691 (Pubitemid 26403635)
13. Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995;34:307-311
14. Muller N, Riedel M, Erfurth A, et al. Immunoglobulin therapy in Gilles de la Tourette syndrome [in German]. Nervenarzt 1997;68:914-916 (Pubitemid 27521423)
15. Perlmutter SJ, Garvey MA, Castellanos X, et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 1998;155:1592-1598 (Pubitemid 28512030)
16. Perlmutter SJ, Garvey MA, Castellanos X, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999;354:1153-1158 (Pubitemid 29460444)
17. Murphy TK, Goodman WK, Fudge MW, et al. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry 1997;154:402-407
18. Bruun RD, Budman CL. The course and prognosis of Tourette syndrome. Neurol Clin 1997;15:291-298 (Pubitemid 27202915)
19. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 1993;50:1013-1016
20. Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566-573 (Pubitemid 19196295)
21. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
22. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 2: validity. Arch Gen Psychiatry 1989;46:1012-1016
23. Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997;36:844-852 (Pubitemid 27250450)
24. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:217-222
25. Santangelo SL, Pauls DL, Lavori PW, et al. Assessing risk for the Tourette spectrum of disorders among first-degree relatives of probands with Tourette syndrome. Am J Med Genet 1996;67:107-116 (Pubitemid 26100565)
26. Church AJ, Dale RC, Lees AJ, et al. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003;74:602-607 (Pubitemid 36528904)
27. Levy Y, Sherer Y, George J, et al. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 1999;119:231-238 (Pubitemid 29326997)